Skip to main content

Advertisement

Log in

Evidence Expands Total Gastrectomy Decision for Asymptomatic Patients with CDH1 Inherited Mutations

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Chen Y, Kingham K, Ford JM, et al. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Ann Surg Oncol. 2011 [Epub ahead of print]. doi:10.1245/s10434-011-1648-9.

  2. Ziogas D, Roukos DH. CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol. 2009;16:2678–81.

    Article  PubMed  Google Scholar 

  3. Pandalai PK, Lauwers GY, Chung DC, Patel D, Yoon SS. Prophylactic total gastrectomy for individuals with germline CDH1 mutation. Surgery. 2011;149:347–55.

    Article  PubMed  Google Scholar 

  4. Hackenson D, Edelman DA, McGuire T, Weaver DW, Webber JD. Prophylactic laparoscopic gastrectomy for hereditary diffuse gastric cancer: a case series in a single family. JSLS. 2010;14:348–52.

    Article  PubMed  Google Scholar 

  5. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010;9:775–89.

    Article  PubMed  CAS  Google Scholar 

  6. Roukos DH. Cancer genome explosion and systems biology: Impact on surgical oncology? Ann Surg Oncol. 2011;18(1):12–5.

    Article  PubMed  Google Scholar 

  7. Roukos DH, Ziogas D. From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther. 2010;10(2):123–8.

    Article  PubMed  CAS  Google Scholar 

  8. Roukos DH. Isolated tumor cells in breast cancer. N Engl J Med. 2009;361:1994–5; author reply 1995–6.

  9. Roukos DH. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn. 2010;10(3):247–50.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Liakakos MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liakakos, T. Evidence Expands Total Gastrectomy Decision for Asymptomatic Patients with CDH1 Inherited Mutations. Ann Surg Oncol 18 (Suppl 3), 206–207 (2011). https://doi.org/10.1245/s10434-011-1837-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-011-1837-6

Keywords

Navigation